Author Archives for Adeline Chauvigné

Biomedical Tissues raises €500K for the marketing and commercialisation of its landmark product – Tisseos®

6 June 2025

Biomedical Tissues, Atlanpole Biotherapies member and a medtech company, completed a €0.5 million capital increase over the summer. The funds... View Article

In-Cell-Art : Pass trough new steps for their Nanotaxi®

6 June 2025

In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies named Nanotaxi® designed to unlock the promise of nucleic acids to... View Article

Association of OSE Immunotherapeutics with GERCOR

6 June 2025

OSE Immunotherapeutics Partners with Oncology Physician Network GERCOR to Conduct a Combination Phase 2 Trial of Tedopi® for Pancreatic Cancer.... View Article

ArronaxPlus [video]

6 June 2025

ArronaxPlus presentation in video !

In-Cell-Art Announces Extension of a second Research Service Agreement with a Global Independent Vaccine Company

6 June 2025

In-Cell-Art (ICA), a biotechnology company specializing in nanocarrier technologies named Nanotaxi® for unlocking the promise of nucleic acids to treat... View Article

InFlectis BioScience strengthens its intellectual property position in Europe and in the USA

6 June 2025

InFlectis BioScience strengthens its intellectual property position in Europe and in the USA InFlectis BioScience SAS, a biopharmaceutical company specializing... View Article

OSE Immunotherapeutics Announces Temporary Pause of Patient Accrual

6 June 2025

OSE Immunotherapeutics Announces Temporary Pause of Patient Accrual While Continuing Treatment for Patients Already Enrolled In Phase 3 Clinical Trial... View Article

OSE Immunotherapeutics Receives Payment of €2.6 Million from Bpifrance

6 June 2025

OSE Immunotherapeutics Receives Payment of €2.6 Million from Bpifrance After Completion of a New Key Milestone for its Product OSE-127... View Article

OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration with Memorial Sloan Kettering Cancer Center

6 June 2025

OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration with Memorial Sloan Kettering Cancer Center in New York Focused on Company’s Cytotoxic... View Article

What’s up France Biotech

6 June 2025

After Paris, Lille and Marseille, France Biotech stopped over in Nantes to present an overview of the Life Science industry... View Article